Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

FMTXFMTX
10 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in FORMA THERAPEUTICS HOLDINGS

As of its Q3 2022 13F, RhumbLine Advisers held 64,945 shares of FMTX (Forma Therapeutics Holdings), worth $1.3M. RhumbLine Advisers' 13F filings listed FMTX from Q3 2020 to Q3 2022, 9 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$879,000

Total Shares Change

-17,633

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2022-Q3
Increased
64,945
+10.6%
$1.3M0.0%—
28
2022-Q2
Increased
58,732
+34.9%
$405,0000.0%—
31
2022-Q1
Decreased
43,550
-3.1%
$405,0000.0%—
0
2021-Q4
Increased
44,923
+1.2%
$639,0000.0%—
25
2021-Q3
Increased
44,391
+4.4%
$1M0.0%—
26
2021-Q2
Increased
42,516
+35.7%
$1.1M0.0%—
33
2021-Q1
Increased
31,340
+58.0%
$878,0000.0%—
35
2020-Q4
Increased
19,834
+12.5%
$692,0000.0%—
28
2020-Q3
New
17,633
-
$879,0000.0%—
34

Other major holders of FMTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used